Four cases (10%) of ASXL1 mutations were observed in patients with AML, three of which were related to secondary AML (with previous diagnoses of CMML, CML and CML), and one was associated with primary AML (Table S1). Here, ASXL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.